A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks
Copyright © 2020 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights reserved..
Cytokine-Induced (CIK) cells represent an attractive approach for cell-based immunotherapy, as they show several advantages compared with other strategies. Here we describe an original serum-free protocol for CIK cell expansion that employs G-Rex devices and compare the resulting growth, viability, phenotypic profile and cytotoxic activity with conventional culture in tissue flasks. CIK cells were obtained from buffy coats, seeded in parallel in G-Rex and tissue flasks, and stimulated with clinical-grade IFN-γ, anti-CD3 antibody and IL-2. G-Rex led to large numbers of CIK cells, with a minimal need for technical interventions, thus reducing the time and costs of culture manipulation. CIK cells generated in G-Rex showed a less differentiated phenotype, with a significantly higher expression of naive-associated markers such as CD62L, CD45RA and CCR7, which correlates with a remarkable expansion potential in culture and could lead to longer persistence and a more sustained anti-tumor response in vivo. The described procedure can be easily translated to large-scale production under Good Manufacturing Practice. Overall, this protocol has strong advantages over existing procedures, as it allows easier, time-saving and cost-effective production of CIK effector cells, fostering their clinical application.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Cytotherapy - 22(2020), 9 vom: 01. Sept., Seite 511-518 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Palmerini, Pierangela [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adoptive cell therapy |
|---|
| Anmerkungen: |
Date Completed 19.02.2021 Date Revised 19.02.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jcyt.2020.05.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312093659 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312093659 | ||
| 003 | DE-627 | ||
| 005 | 20231225143654.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcyt.2020.05.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1040.xml |
| 035 | |a (DE-627)NLM312093659 | ||
| 035 | |a (NLM)32631696 | ||
| 035 | |a (PII)S1465-3249(20)30680-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Palmerini, Pierangela |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.02.2021 | ||
| 500 | |a Date Revised 19.02.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Cytokine-Induced (CIK) cells represent an attractive approach for cell-based immunotherapy, as they show several advantages compared with other strategies. Here we describe an original serum-free protocol for CIK cell expansion that employs G-Rex devices and compare the resulting growth, viability, phenotypic profile and cytotoxic activity with conventional culture in tissue flasks. CIK cells were obtained from buffy coats, seeded in parallel in G-Rex and tissue flasks, and stimulated with clinical-grade IFN-γ, anti-CD3 antibody and IL-2. G-Rex led to large numbers of CIK cells, with a minimal need for technical interventions, thus reducing the time and costs of culture manipulation. CIK cells generated in G-Rex showed a less differentiated phenotype, with a significantly higher expression of naive-associated markers such as CD62L, CD45RA and CCR7, which correlates with a remarkable expansion potential in culture and could lead to longer persistence and a more sustained anti-tumor response in vivo. The described procedure can be easily translated to large-scale production under Good Manufacturing Practice. Overall, this protocol has strong advantages over existing procedures, as it allows easier, time-saving and cost-effective production of CIK effector cells, fostering their clinical application | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Adoptive cell therapy | |
| 650 | 4 | |a Cytokine-Induced Killer cells | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Serum-free | |
| 650 | 4 | |a ex vivo expansion | |
| 650 | 7 | |a Culture Media, Serum-Free |2 NLM | |
| 650 | 7 | |a Gases |2 NLM | |
| 700 | 1 | |a Dalla Pietà, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Sommaggio, Roberta |e verfasserin |4 aut | |
| 700 | 1 | |a Ventura, Annavera |e verfasserin |4 aut | |
| 700 | 1 | |a Astori, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Chieregato, Katia |e verfasserin |4 aut | |
| 700 | 1 | |a Tisi, Maria Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Visco, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Perbellini, Omar |e verfasserin |4 aut | |
| 700 | 1 | |a Ruggeri, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Cappuzzello, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Rosato, Antonio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cytotherapy |d 1999 |g 22(2020), 9 vom: 01. Sept., Seite 511-518 |w (DE-627)NLM118333852 |x 1477-2566 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2020 |g number:9 |g day:01 |g month:09 |g pages:511-518 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcyt.2020.05.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2020 |e 9 |b 01 |c 09 |h 511-518 | ||